Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-44.18	11.52	20.63
Graham Fair Price	27.18	82164.52	64605.83
PEG	-56.91	-0.04	0.08
Price/Book	-8.67	0.85	0.93
Price/Cash Flow	-51.31	-17.01	34.93
Prices/Earnings	-38.69	9.15	-14.92
Price/Sales	4.23	0.82	0.79
Price/FCF	-51.31	-17.01	34.93
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	21.24	0.26	0.21
Operating Margin	367.10	0.06	0.01
ROA	52.37	< 0.005	< 0.005
ROE	-0.02	0.02	48.95
ROIC	< 0.005	0.03	259.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	< 0.005	79.88
Dividends QOQ	1168.00	-1.00	-99.91
EBIT QOQ	-0.69	3.26	376.05
EPS QOQ	-1.79	2.55	42.30
FCF QOQ	-0.06	-2.95	-4911.58
Revenue QOQ	0.12	-0.09	-24.83
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	45.03	57.50	27.69
Days Sales Outstanding (DSO)	43.69	52.62	20.44
Inventory Turnover	2.00	1.57	-21.69
Debt/Capitalization	0.41	0.40	-1.36
Quick Ratio	0.82	0.81	-1.31
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	109208.63	113801.78	4.21
Cash	47697.52	39698.04	-16.77
Capex	-5628.78	-5228.89	7.10
Free Cash Flow	2902.80	-5673.48	95.45
Revenue	128309.09	117156.53	-8.69
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.26	1.29	2.73
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.12	3.55	-30.65
Naive Interpretation	Member

06 - Financial Health · Weak

Rating